Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,944,514 papers from all fields of science
Search
Sign In
Create Free Account
exifone
Known as:
hexahydro-2,3,4,3',4',5'-benzophenone
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
Adlone brand of exifone
Broader (1)
Benzophenones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer
W. M. Berhanu
,
A. Masunov
Journal of Biomolecular Structure and Dynamics
2015
Corpus ID: 2617539
Amyloid fibrils are highly ordered protein aggregates associated with many diseases affecting millions of people worldwide…
Expand
2006
2006
A convenient approach for evaluating the toxicity profiles of in vitro neuroprotective alkylaminophenol derivatives.
A. Urios
,
M. Largeron
,
M. Fleury
,
M. Blanco
Free Radical Biology & Medicine
2006
Corpus ID: 19182427
2005
2005
Synergistic antimalarial activity of ketones with rufigallol and vitamin C
S. Mahajan
,
V. Kamath
,
S. Ghatpande
Parasitology
2005
Corpus ID: 38628330
Malaria remains a major cause of human morbidity and mortality worldwide. Plasmodium falciparum, the most virulent of the 4 human…
Expand
2004
2004
Antagonism by exifone, a new cognitive enhancing agent, of the amnesias induced by four benzodiazepines in mice
R. Porsolt
,
A. Lenègre
,
I. Avril
,
G. Doumont
Psychopharmacology
2004
Corpus ID: 10872352
Exifone is a novel compound proposed for treating cognitive decline associated with age and shows corrective effects in animal…
Expand
1999
1999
Free radical involvement in endothelium-dependent responses of the rat thoracic aorta in moderate hypoxic conditions.
B. Saïag
,
V. Shacoori
,
P. Bodin
,
D. Pape
,
H. Allain
,
G. Burnstock
European Journal of Pharmacology
1999
Corpus ID: 2161211
1997
1997
Potentiation of an antimalarial oxidant drug
R. Winter
,
M. Ignatushchenko
,
+4 authors
M. Riscoe
Antimicrobial Agents and Chemotherapy
1997
Corpus ID: 46728428
In a previous report we described the synergistic antimalarial interaction between two structurally similar compounds, rufigallol…
Expand
Highly Cited
1996
Highly Cited
1996
Potentiation of the antimalarial agent rufigallol
R. Winter
,
K. Cornell
,
L. Johnson
,
M. Ignatushchenko
,
D. Hinrichs
,
M. Riscoe
Antimicrobial Agents and Chemotherapy
1996
Corpus ID: 44514043
We have discovered a remarkable synergistic antimalarial interaction between rufigallol and the structurally similar compound…
Expand
1989
1989
COMPARATIVE EVALUATION OF SCAVENGER PROPERTIES OF EXIFONE, PIRACETAM AND VINBURNINE
Danièle Bentué-Ferrer
,
V. Philouze
,
D. Pape
,
J. Reymann
,
H. Allain
,
J. Driessche
Fundamental & Clinical Pharmacology
1989
Corpus ID: 39445136
Summary— The involvement of radical reactions in the ageing process, physiological as well as pathological, is well demonstrated…
Expand
1989
1989
[A case of hepatitis caused by exifone and bezafibrate].
C. Gendreau-Tranquart
,
J. Barbieux
,
+5 authors
E. Metman
Gastroentérologie Clinique et Biologique
1989
Corpus ID: 42672114
1988
1988
RANDOMIZED, DOUBLE‐BLIND TRIAL OF EXIFONE VERSUS COGNITIVE PROBLEMS IN PARKINSON'S DISEASE
H. Allain
,
J. Denmat
,
+6 authors
J. Driessche
Fundamental & Clinical Pharmacology
1988
Corpus ID: 7036155
Summary— Exifone is a novel substance of the benzophenone group that possesses potent scavenging properties. Initial findings…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required